rabbit anti-histag polyclonal antibody (Santa Cruz Biotechnology)
Structured Review
Rabbit Anti Histag Polyclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti-histag+polyclonal+antibody/horseradish+peroxidase+conjugated+secondary+antibody/pm28738734-40-1-14
Average 90 stars, based on 1 article reviews
Images
Related Articles
Reverse Transcription Polymerase Chain Reaction:Article Title: A tissue factor-cascade-targeted nanoparticle forsite-directed inducing thrombosis. Article Snippet: Tissue factor is an upstream component of the cascade and a high-expressing factor under phathological conditions.. In this study, a tissue factor cascade-targeted strategy for inducing local thrombosis was developed by combining ENPHMME and photochemistry.. In vitro study showed that protein EGFP-EGF1 conjugation to the nanoparticles could significantly contribute to the uptake of nanoparticles by tissue factor over-expressed brain capillary endothelial cells. Article Title: A tissue factor targeted nanomedical system for thrombi-specific drug delivery. Article Snippet: Tissue factor (TF) is a 47 kDa membrane-bound glycoprotein, which is present at high concentrations on damaged endothelium, atherosclerotic plaques or tumor vasculature, and is an important trigger of coagulation cascade.. In this study, we have expressed and purified the TF targeting protein-EGFP-EGF1, which was thiolated and conjugated to the malemide of the PEG-PLGA nanoparticle to form a TF targeting nanomedical system: EGF1-EGFP-NP.. The system was carefully characterized and the targeting efficiency was systematically evaluated. Article Title: The delivery of thrombi-specific nanoparticles incorporating oligonucleotides into injured cerebrovascular endothelium. Article Snippet: In acute vascular events, the endothelium derived tissue factor (TF) is the trigger of the coagulation cascade.. In this study, EGFP-EGF1 protein-conjugated PEG-PLGA nanoparticle was employed as a TF targeting vehicle, the NF-kB decoy oligonucleotides (ODNs) was incorporated into it and the resulting EGF1-EGFP-NP-ODNs were evaluated as a vector for therapy of cortex infarction.. At 2 h after transfection of TF expressed rat brain capillary endothelial cell, EGF1-EGFP-NP-ODNs was more efficiently internalized and located in the cytoplasm than NP-ODNs. Labeling:Article Title: A tissue factor-cascade-targeted nanoparticle forsite-directed inducing thrombosis. Article Snippet: Tissue factor is an upstream component of the cascade and a high-expressing factor under phathological conditions.. In this study, a tissue factor cascade-targeted strategy for inducing local thrombosis was developed by combining ENPHMME and photochemistry.. In vitro study showed that protein EGFP-EGF1 conjugation to the nanoparticles could significantly contribute to the uptake of nanoparticles by tissue factor over-expressed brain capillary endothelial cells. Article Title: A tissue factor targeted nanomedical system for thrombi-specific drug delivery. Article Snippet: Tissue factor (TF) is a 47 kDa membrane-bound glycoprotein, which is present at high concentrations on damaged endothelium, atherosclerotic plaques or tumor vasculature, and is an important trigger of coagulation cascade.. In this study, we have expressed and purified the TF targeting protein-EGFP-EGF1, which was thiolated and conjugated to the malemide of the PEG-PLGA nanoparticle to form a TF targeting nanomedical system: EGF1-EGFP-NP.. The system was carefully characterized and the targeting efficiency was systematically evaluated. Article Title: The delivery of thrombi-specific nanoparticles incorporating oligonucleotides into injured cerebrovascular endothelium. Article Snippet: In acute vascular events, the endothelium derived tissue factor (TF) is the trigger of the coagulation cascade.. In this study, EGFP-EGF1 protein-conjugated PEG-PLGA nanoparticle was employed as a TF targeting vehicle, the NF-kB decoy oligonucleotides (ODNs) was incorporated into it and the resulting EGF1-EGFP-NP-ODNs were evaluated as a vector for therapy of cortex infarction.. At 2 h after transfection of TF expressed rat brain capillary endothelial cell, EGF1-EGFP-NP-ODNs was more efficiently internalized and located in the cytoplasm than NP-ODNs. |


